- Home
- ALXO vs MKTW Comparison
ALXO vs MKTW Comparison
Compare ALXO & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- MKTW
- Stock Information
- Founded
- ALXO 2015
- MKTW 1999
- Country
- ALXO United States
- MKTW United States
- Employees
- ALXO N/A
- MKTW N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- ALXO Health Care
- MKTW Technology
- Exchange
- ALXO Nasdaq
- MKTW Nasdaq
- Market Cap
- ALXO 28.3M
- MKTW 30.3M
- IPO Year
- ALXO 2020
- MKTW N/A
- Fundamental
- Price
- ALXO $0.42
- MKTW $15.13
- Analyst Decision
- ALXO Strong Buy
- MKTW
- Analyst Count
- ALXO 6
- MKTW 0
- Target Price
- ALXO $3.54
- MKTW N/A
- AVG Volume (30 Days)
- ALXO 515.3K
- MKTW 40.3K
- Earning Date
- ALXO 05-08-2025
- MKTW 05-08-2025
- Dividend Yield
- ALXO N/A
- MKTW 4.90%
- EPS Growth
- ALXO N/A
- MKTW 207.28
- EPS
- ALXO N/A
- MKTW 3.12
- Revenue
- ALXO N/A
- MKTW $383,217,000.00
- Revenue This Year
- ALXO N/A
- MKTW N/A
- Revenue Next Year
- ALXO N/A
- MKTW $0.42
- P/E Ratio
- ALXO N/A
- MKTW $4.43
- Revenue Growth
- ALXO N/A
- MKTW N/A
- 52 Week Low
- ALXO $0.44
- MKTW $9.08
- 52 Week High
- ALXO $17.50
- MKTW $33.60
- Technical
- Relative Strength Index (RSI)
- ALXO 31.14
- MKTW 65.66
- Support Level
- ALXO $0.49
- MKTW $13.01
- Resistance Level
- ALXO $0.55
- MKTW $14.29
- Average True Range (ATR)
- ALXO 0.05
- MKTW 0.91
- MACD
- ALXO 0.00
- MKTW 0.09
- Stochastic Oscillator
- ALXO 4.92
- MKTW 88.89
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.